Research Article
Renal and Inflammatory Proteins as Biomarkers of Diabetic Kidney Disease and Lupus Nephritis
Table 1
Patients with DKD and lupus nephritis used in the study.
| | DKD patients | 31 |
| | LN patients | 32 |
| | Sex (DKD) | Males (55%)–female (45%) | | 17 - 14 |
| | Sex (LN) | Males (25%)–female (72%)–unspecified (3%) | | 8–23–1 |
| | Race (DKD) | | | Caucasian | 17 (55%) | | African | 10 (32%) | | Other | 4 (13%) |
| | Race (LN) | | | Caucasian | 17 (53%) | | African | 11 (34%) | | Other | 4 (13%) |
| | Age range (DKD) | | | Range | 21 - 90 | | Median | 62 | | Mean | 63.32 |
| | Age range (LN) | | | Range | 19 - 75 | | Median | 43.5 | | Mean | 44.91 |
| | Comorbidities (DKD) | | | HTN | 23 (74%) | | Hypercholesterolemia | 6 (19%) | | Hypothyroidism | 8 (26%) | | GERD | 7 (23%) | | CAD | 7 (23%) | | Diabetes type I | 2 (6%) | | Diabetes type II | 21 (68%) | | Diabetes (type unspecified) | 8 (26%) |
| | Comorbidities (LN) | | | HTN | 6 (19%) | | GERD | 2 (6%) | | CAD | 3 (9%) |
| | Disease stage (DKD) | | | 2 | 1 (3%) | | 3 | 7 (22%) | | 4 | 2 (7%) | | 5 | 2 (7%) | | Unspecified | 19 (61%) |
| | Disease stage (LN) | | | 1 | 4 (12%) | | 3 | 6 (19%) | | 4 | 5 (16%) | | 5 | 2 (6%) | | Unspecified | 15 (47%) |
|
|
HTN: hypertension; GERD: gastroesophageal reflux disease; CAD: coronary artery disease.
|
